As of now, Dr. Chang holds over 5 million shares in Allogene Therapeutics, which is about 4.1% of the company. His shares come from a mix of personal investments and stock options. Notably, in prior years, his stock options were...

As of now, Dr. Chang holds over 5 million shares in Allogene Therapeutics, which is about 4.1% of the company. His shares come from a mix of personal investments and stock options. Notably, in prior years, his stock options were valued at upwards of $57 million, showcasing how his involvement in the company has a direct impact on his wealth. However, all of his stock is subject to vesting restrictions, meaning he is aligned with the company’s long-term success. While he had a significant number of options granted in earlier years, like 568,600 in 2020, he has shifted focus to performance bonuses, which have also fluctuated based on the company's achievements.